1. Home
  2. NVTS vs MNKD Comparison

NVTS vs MNKD Comparison

Compare NVTS & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Navitas Semiconductor Corporation

NVTS

Navitas Semiconductor Corporation

HOLD

Current Price

$8.12

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$5.86

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVTS
MNKD
Founded
2014
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
NVTS
MNKD
Price
$8.12
$5.86
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$5.92
$10.08
AVG Volume (30 Days)
18.2M
2.8M
Earning Date
11-03-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
23.47
EPS
N/A
0.10
Revenue
$56,598,000.00
$313,787,000.00
Revenue This Year
N/A
$21.54
Revenue Next Year
N/A
$22.21
P/E Ratio
N/A
$60.68
Revenue Growth
N/A
17.43
52 Week Low
$1.52
$3.38
52 Week High
$17.79
$7.07

Technical Indicators

Market Signals
Indicator
NVTS
MNKD
Relative Strength Index (RSI) 41.67 61.46
Support Level $8.01 $5.59
Resistance Level $10.24 $6.01
Average True Range (ATR) 0.66 0.19
MACD 0.06 0.05
Stochastic Oscillator 20.60 83.52

Price Performance

Historical Comparison
NVTS
MNKD

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: